P.4.b.003 - Efficacy and safety of 2 doses of agomelatine (10 mg/day or 25 mg/day) versus placebo in generalized anxiety disorder
| Autor: | Stein, D., Ahokas, A., Jarema, M., Avedisova, A.S., Vavrusova, L., Chaban, O., Olivier, V., Gruget, C., Picarel-Blanchot, F., De Bodinat, C. |
|---|---|
| Zdroj: | In European Neuropsychopharmacology October 2016 26 Supplement 2:S601-S602 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect